Caelyx pegylated liposomal 2 mg/ml concentrate for solution for infusion
*Company:
Baxter Holding B.V.Status:
No Recent UpdateLegal Category:
Product subject to medical prescription which may not be renewed (A)Active Ingredient(s):
*Additional information is available within the SPC or upon request to the company
Updated on 02 August 2023
File name
HA3002067_(753511)_LABEL_21APR2023_P01 - Caelyx IE.pdf
Reasons for updating
- New PIL for new product
Updated on 23 January 2023
File name
caelyx-smpc-EU-1-96-011-001-004-Aug-2021.pdf
Reasons for updating
- Document format updated
Legal category:Product subject to medical prescription which may not be renewed (A)
Updated on 12 October 2021
File name
caelyx-smpc-EU-1-96-011-001-004-Aug-2021.pdf
Reasons for updating
- New SPC for new product
Legal category:Product subject to medical prescription which may not be renewed (A)
Baxter Holding B.V.
Address:
Kobaltweg 49, 3542CE Utrecht, NetherlandsMedical Information E-mail:
medinfo_uki@baxter.comTelephone:
+44 (0)1635 206 345Medical Information Facsimile:
+44 (0)1635 206071Medical Information Direct Line:
+44 (0)1635 206345